Pharmaceutical & Biologics advances in pharmaceuticals and biologics have actually improved the health of millions of individuals, reduced the frequency of avoidable diseases, and allowed for chronic illness to kept over an extended duration of time. These advances have extended life span for countless people, especially those with chronic illness and some cancers.Nevertheless, the escalating expenses of pharmaceuticals and biologics places these interventions and treatments out of reach for far too lots of people. Policies should be developed that enable purchasers of health care, including Medicare, to work out the expenses of prescription drugs. Additionally, there need to be higher versatility in the design of formularies that permit increased use of generic and bio-similar products.